Pharmacogenetics of migraine: genetic variants and their potential role in migraine therapy.

Abstract excerpt

Migraine is a paroxysmal neurological disorder affecting up to 6% of males and 18% of females in the general population, and has been demonstrated to have a strong, but complex, genetic component. Genetic investigation of migraine provides hope that new targets for medications and individual specific therapy will be developed. The identification of polymorphisms or genetic biomarkers for disease susceptibility...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Pharmacogenetics
• Share to Genetic Variation
• Share to Migraine Disorders